drugset / Press release

New Data Presented at ESMO 2017 Shows That Abiraterone Acetate Plus Prednisone Provides Benefits in Patient Reported Outcomes in Both Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer

2017-09-08 · Janssen Research & Development, LLC · original jnj.com ↗

Abiraterone acetate · results Prednisone

NEWS RELEASE New Data Presented at ESMO 2017 Shows That Abiraterone Acetate Plus Prednisone Provides Benets in Patient Reported Outcomes in Both Metastatic Hormone-Sensitive and Castration- Resistant Prostate Cancer 9/8/2017 1

The release as fetched from its publisher. jnj.com ↗